Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsSafety monitoring
Spravato has important risks, so treatment is administered only in a certified healthcare setting with monitoring after dosing.
Multi-location Spravato access across NYC and Long Island, with care-manager support, Medicaid access, and clinic options that account for repeated monitored visits.
Spravato may cause sedation, dissociation, dizziness, nausea, increased blood pressure, vertigo, anxiety, vomiting, and other side effects. The care team monitors patients after dosing and checks whether they are clinically stable before leaving.
Spravato is restricted under a REMS program because of risks including sedation, dissociation, respiratory depression, abuse, and misuse. The certified healthcare setting requirement is designed to support safer administration and monitoring.
Clinical references reviewed: SPRAVATO REMS and the FDA prescribing information. Last reviewed May 2026. This information does not replace a clinical evaluation.
Queens
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsBronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for patients who want local Spravato care without leaving the borough.
View location detailsLong Island
232 W Old Country Rd, Hicksville, NY 11801
A central Nassau option for patients who need consistent follow-up, prior auth support, and a shorter commute.
View location detailsQueens
90-18 Sutphin Blvd, Jamaica, NY 11435
A southeast Queens location that helps patients stay on schedule for repeated monitored sessions.
View location detailsQueens
30-07 36th Ave, Astoria, NY 11106
A western Queens access point for patients balancing treatment days with work, home, or Manhattan commutes.
View location detailsLong Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for patients who want strong benefits support and reliable treatment coordination.
View location detailsManhattan
259 1st Ave, New York, NY 10003
A Manhattan Spravato access point for East Village, Gramercy, Kips Bay, and nearby neighborhoods.
View location detailsBrooklyn
308 Graham Ave, Brooklyn, NY 11211
The lead Brooklyn Spravato location for patients who want local access and ongoing psychiatric support.
View location detailsPatients are monitored for at least two hours after dosing and are assessed before leaving the healthcare setting.
Yes, blood pressure increases can occur. Blood pressure is reviewed as part of treatment-day safety planning.
Report severe sedation, breathing concerns, chest pain, severe headache, confusion, worsening mood, or any symptom that feels urgent.
Patients should avoid driving, operating machinery, and high-risk activities until the next day after restful sleep.